Animal Model Market is estimated to be US$ 3.6 billion by 2032 and is anticipated to register a CAGR of 6.6% – By Allied

Key factors driving the growth of animal model market include rise in usage of animal models in virology and infectious diseases, physiological similarity of humans and animals for drug testing, increase in adoption of CRISPR technology.

According to the report, the global animal model market was valued at $1.9 billion in 2022 and is estimated to reach $3.6 billion by 2032, exhibiting a CAGR of 6.6% from 2023 to 2032.

Request Sample of the Report: 

https://www.alliedmarketresearch.com/request-sample/8311

The animal model refers to the animal on which pathological and biological experiments are performed & tested. Animal models are utilized as animals mimic the physiological & organic structures of humans. In addition, some of the animal species share nearly similar genetic structures to humans. Thus, animal models are utilized by scientists and researchers to study & find a cure for diseases, test the final medicinal drug before it is used on humans, and develop new products. Moreover, animal models find applications in drug discovery & development and basic research, as new drugs are examined in animals for safety & efficacy before they are examined in humans.

Impact of COVID-19 on Animal Model Market:

Positive Impacts:

• Increased Research Activity: The urgency to understand, prevent, and treat COVID-19 led to a surge in research activity using animal models. This increased demand for various animal models, including mice, hamsters, ferrets, and non-human primates, boosting the market value and revenue of animal model suppliers.
• Focus on Emerging Models: The limitations of some traditional animal models for studying COVID-19 highlighted the need for more relevant models, such as humanized mice and organ-on-a-chip technology. This research and development focus could benefit the market for these emerging models in the long term.
• Collaboration and Knowledge Sharing: The pandemic sparked increased collaboration and knowledge sharing among researchers, clinicians, and animal model experts across the globe. This collaborative effort accelerated research progress and potentially improved the quality and utilization of animal models in COVID-19 research.

Negative Impacts:

• Supply Chain Disruptions: Global lockdowns and travel restrictions disrupted the supply chain for animals, breeding materials, and research equipment. This led to shortages of certain animal models and delays in research projects.
• Ethical Concerns and Regulatory Challenges: The intense focus on COVID-19 research raised concerns about animal welfare and the ethical use of animals in research. Balancing scientific progress with animal welfare remains a crucial challenge.
• Financial Strain on Research Institutions: The pandemic’s economic impact led to budget cuts and funding uncertainties for many research institutions. This put pressure on animal model facilities and potentially limited access to necessary resources for some researchers.

Request for Customization – 

https://www.alliedmarketresearch.com/request-for-customization/8311

The growth of the global animal model market is attributed to factors such as the rise in the usage of animal models in virology and infectious diseases, the physiological similarity of humans and animals for drug testing, and the increase in adoption of CRISPR technology. On the other hand, the availability of alternative testing methods to restrain market growth during the forecast period. Moreover, high growth potential in emerging markets is anticipated to present significant opportunities for market growth during the forecast period.

Key Market Segments:

Key Findings of the Study:

• Depending on animal type, the mice segment held the largest animal model industry share in 2022.
• On the basis of application, the drug discovery & development segment held the largest market share in 2022.
• By end user, the pharma & biotech companies segment held the largest market share in 2022.
• Region-wise, North America registered the highest animal model industry share in 2022. However, Asia-Pacific is expected to exhibit the fastest growth during the forecast period.

For Purchase Inquiry –

https://www.alliedmarketresearch.com/purchase-enquiry/8311

Leading Market Players: - 

• Hera Biolabs
• Crown Bioscience Inc.
• Janvier Labs, LLC
• Inotiv, Inc.
• Charles River Laboratories
• The Jackson Laboratory.
• Genoway S.A.
• Trans Genic Inc.
• Ozgene Pty Ltd.
• Taconic Biosciences

Regional Analysis:

North America held the highest market share in terms of revenue in 2022, accounting for more than two-fifths of the global animal model market revenue, and is likely to dominate the market during the forecast period. Due to the surge in research and development activities by pharma and biotech companies and the strong presence of key players to provide animal models to meet the demand. However, the Asia-Pacific region is expected to witness the fastest CAGR of 8.0% from 2023 to 2032. This is attributed to the well-developed vaccine industry in this region and the high level of research and development for the development of new vaccines.

Other Trending Reports in Life Science Domain- 

Chlorpheniramine Maleate Market:

https://www.alliedmarketresearch.com/chlorpheniramine-maleate-market

Penicillin Drug Market:

https://www.alliedmarketresearch.com/penicillin-drug-market-A110795

Radiology Information System Market:

https://www.alliedmarketresearch.com/radiology-information-systems-market

About Us:

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

Contact Us:

David Correa

Portland, OR, United States

USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022,

UK: +44-845-528-1300

Hong Kong: +852-301-84916

India (Pune): +91-20-66346060

Fax: +1(855)550-5975

help@alliedmarketresearch.com

Web: https://www.alliedmarketresearch.com